06 Sep 2017 Argos Announces First Dosing of HIV Patient with AGS-004 Derived from the Latent Viral Reservoir
06 Sep 2017 AbbVie Submits New Drug Application to U.S. FDA for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain
06 Sep 2017 Aelix Therapeutics Enrolls First Patient In Company’s Initial Therapeutic HIV Vaccine Clinical Trial
05 Sep 2017 VAXIMM Announces Preclinical Results with Novel Oral T-cell Cancer Immunotherapies Being Presented at Third CRI-CIMT-EATI-AACR Conference
01 Sep 2017 PepVax begins efficacy study for lead candidate
29 Aug 2017 Gliknik Announces Dosing Of First Patient In Phase 2 Trial Targeting Prevention Of Recurrence Of High-Risk Oral Cavity Cancer
21 Aug 2017 Altimmune Submits Investigational New Drug Application for NasoVAX in Preparation for Phase 2 Trial
16 Aug 2017 VBI Vaccines Announces FDA Acceptance of Investigational New Drug Application for VBI-1901 to Treat Glioblastoma Multiforme
11 Aug 2017 Immunicum AB (publ) Announces Enrollment of First United States Patient in the Ongoing Phase 2 MERECA Trial for Ilixadencel
02 Aug 2017 Madison Vaccines Announces First Patient Dosed in an Expanded Combination Trial of MVI-816 Plus Keytruda® for Metastatic, Treatment-Resistant Prostate Cancer
01 Aug 2017 Dynavax Announces FDA Advisory Committee Vote in Favor of HEPLISAV-B
29 Jul 2017 VBI Vaccines Announces Positive Interim Data from Phase 1 Study of Preventative CMV Vaccine
27 Jul 2017 Chikungunya-fever: Themis Bioscience starts phase II clinical study in endemic area
27 Jul 2017 CureVac Announces Publication in The Lancet of First-Ever Human Proof-of-Concept Study Investigating the Safety and Immunogenicity of a Prophylactic mRNA Vaccine
27 Jul 2017 Emergent BioSolutions Secures Exclusive Worldwide Rights to Valneva’s Zika Vaccine Technology
25 Jul 2017 Novavax Announces Positive Topline Data from Phase 2 Older Adult Trial and Provides Path Forward for RSV F Vaccine Programs
24 Jul 2017 Genocea Reports Positive Top-Line 12-Month Phase 2b Data for GEN-003 in Genital Herpes
24 Jul 2017 Johnson & Johnson Announces Encouraging First-in-Human Clinical Data for Investigational HIV Preventive Vaccine
24 Jul 2017 VALNEVA Receives FDA Fast Track Designation for its Lyme Disease Vaccine Candidate VLA15
20 Jul 2017 BriaCell Provides Clinical Update on its Ongoing Phase I/IIa Clinical Study of BriaVaxTM in Advanced Breast Cancer
19 Jul 2017 Biothera Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Study Evaluating Combination of Imprime PGG and Merck’s KEYTRUDA in Non-Small Cell Lung Cancer
18 Jul 2017 AXON's Tau Vaccine Has Completed Phase II Enrolment in Alzheimer's
14 Jul 2017 Publication in Cell Demonstrates Moderna’s Zika mRNA Vaccine Prevents In Utero Transmission of Zika Virus in Mice, Protects Against Zika-Related Congenital Damage
12 Jul 2017 Meissa Vaccines awarded $1.6m Fast Track SBIR Grant to advance IND preparations for RSV vaccine candidate
06 Jul 2017 Nature Publication Reports Favorable Clinical Trial Results of BioNTech’s Individualized Cancer Vaccine IVAC® MUTANOME

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing